Compare TeraWulf Inc (WULF) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TeraWulf Inc vs Zimmer Biomet Holdings Inc — how do they compare? TeraWulf Inc trades at $13.77 (market cap $6.81B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.5× TeraWulf Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TeraWulf Inc for 17 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WULF | ZBH | |
|---|---|---|
Market Cap | $6.81B | $16.95B |
Volume | 45,841,998 | 2,505,240 |
Sector | Financials | Health |
52-Week High | $28.98 | $103.98 |
52-Week Low | $10.99 | $79.58 |
Typical Hold Time | 17 Days | 89 Days |
Enterprise Value | $9.43B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WULF trades at $13.65, down 5.21% today, amid a bearish technical signal and weak fundamentals. The company reported a net loss of -$661.42M on $168.46M revenue in 2025, with negative margins and high valuation ratios. Recent news highlights volatility tied to AI infrastructure trends, with shares reacting to sector momentum. Cash flow remains positive from financing, but operational and investing cash flows are negative, indicating heavy capital expenditure.
Outlook is mixed: analyst consensus is strongly bullish with a $34.92 price target, but high losses and bearish technicals pose risks. Investment opportunity hinges on successful AI data center pivot, while risks include persistent unprofitability, competitive pressures, and reliance on financing. Investors should weigh growth potential against financial health.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
